tirzepatide treatments silver spring md Compounded Tirzepatide – $179/month – Mint Med Tirzepatide vs. Semaglutide: Which GLP-1
Description
Value Health 2022;25:S9S10
MOUNJARO 12.5mg KwikPen is an injection in a pre-filled pen containing tirzepatide the active substance at a strength of 12.5mg per 0.6ml dose, manufactured by Eli Lilly and Company Limited.[1][5] Tirzepatide is a dual GIP/GLP-1 receptor agonist indicated for patients with type 2 diabetes mellitus and, in markets where MOUNJARO carries the weight management indication, for eligible adults as an adjunct to diet and exercise.[4][5] The 12.5mg dose is the high-dose titration or maintenance step immediately below the maximum 15 mg of tirzepatide in the approved escalation schedule, with each KwikPen delivering four once-weekly subcutaneous doses.[1][5] Looking to buy MOUNJARO 12.5mg KwikPen online
Though not yet FDA-approved specifically for weight loss, it has been fast-tracked for this application
It also does not mean hormone therapy should be started purely as a weight loss add-on
